CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2021; 42(03): 247-254
DOI: 10.1055/s-0041-1732853
Original Article

A Retrospective Study of Factors Affecting Pathway and Time to Diagnosis, Time to Treatment in Children with Cancer in a Single Center in South India

1   Department of Paediatrics, Kasturba Medical College, Mangalore Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
,
Shobha Prasada
2   Department of Microbiology, Kasturba Medical College, Mangalore Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
,
Jayatheerth Joshi
3   Department of Surgery, Kasturba Medical College, Mangalore Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
,
Sadashiva Rao
3   Department of Surgery, Kasturba Medical College, Mangalore Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
› Author Affiliations
Funding None.

Abstract

Introduction The overall cure rate of childhood cancers is above 79% in the developed world, whereas in the developing world, like in India, it is around 50%. It is vital to know the routes of presentation and factors affecting the presentation of childhood cancers in primary, secondary, and tertiary care to design a better survival strategy in childhood cancer.

Objective The aim of this study was to know the factors affecting the time to diagnosis and time to treatment in children with cancers in a single center in South India.

Materials and Methods It was a retrospective cohort study of children diagnosed with cancer between January 1, 2014 and December 31, 2016 at the pediatric oncology unit, KMC Hospital Mangalore, India. The patient interval, time to diagnosis, patient's family, economic background, parental education, and referral pattern were recorded, and its impact on the time taken to diagnosis was studied. The data was analyzed using SPSS 20.0 software.

Results Out of 111 children, 72 were boys (64.8%). Fifty-one (46%) children belonged to the less than 5-year age group. The most common cancer was acute lymphoblastic leukemia, diagnosed in 50% (56/111) children, followed by acute myeloid leukemia in 14/111(12.6%), brain tumors in 9 (8.1%), and neuroblastoma in 10 (9%) children. The median patient interval/patient delay was 14 days (1–90 days), referral interval was 14 days (1–150 days), and overall time to diagnosis was 41 days (1–194 days). The first contact was the pediatrician in 86/111 (77.4%). Sixty-four percent (71/111) referral came from a secondary care hospital, and the remaining from the outpatient clinics. There was no difference in sex and patient interval (p = 0.278) and overall time to diagnosis (p = 0.4169), age (p = 0.041), mother’s education (p = 0.034), and type of cancer (p = 0.013) were three critical factors that determined the time to diagnosis.

Conclusion Majority of the children diagnosed with cancer presented via referral from pediatricians. An equal number of them were referred to as routine and emergency patients. Age, mother's education, and type of cancers were the crucial factors associated with the overall time taken to diagnosis.



Publication History

Article published online:
20 September 2021

© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • WHO. Facts about Hungary. 2011. Available from: http://www.xpatloop.com/news/who_facts_about_health_in_hungary. Accessed July 2, 2021
  • 2 Bashar MA, Thakur JS. Incidence and pattern of childhood cancers in India: Findings from population-based cancer registries. Indian J Med Paediatr Oncol 2017; 38 (02) 240-241
  • 3 Bashar A. Incidence and pattern of childhood cancers in India: findings from population-based cancer registries. Indian J Cancer 2016; 53 (04) 511-512
  • 4 Arora RS, Alston RD, Eden TOB. et al Cancer at ages 15-29 years: the contrasting incidence in India and England. Pediatr Blood Cancer 2012; 58 (01) 55-60
  • Three year report of PBCR. Available from: http://ncdirindia.org/NCRP/ALL_NCRP_REPORTS/PBCR_REPORT_2012_2014/ALL_CONTENT/Printed_Version.htm. Accessed July 2, 2021
  • 6 Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009; 46 (04) 264-273
  • 7 Ganguly S, Kinsey S, Bakhshi S. Childhood cancer in India. Cancer Epidemiol 2021; 71 (Pt B) 101679
  • 8 Reaman GH. A national approach to evaluating delays in diagnosis and treatment: potential implications for age related and geo-political differences in access to care and outcome in children and adolescents with cancer. Pediatr Blood Cancer 2008; 51 (04) 447-448
  • 9 Dang-Tan T, Trottier H, Mery LS. et al Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada. Int J Cancer 2010; 126 (08) 1936-1943
  • 10 Rogers EK, Cannon A, Zaborowski K, Paul SP. Early recognition and management of brain tumours in children. Nurs Stand 2016; 31 (01) 42-49
  • 11 Lethaby CD, Picton S, Kinsey SE. Phillips R, van Laar M, Feltbower RG. A systematic review of time to diagnosis in children and young adults with cancer. Arch Dis Child 2013; 98 (05) 349-355
  • 12 Clarke RT, Jones CHD, Mitchell CD, Thompson MJ. ‘Shouting from the roof tops’: a qualitative study of how children with leukaemia are diagnosed in primary care. BMJ Open 2014; 4 (02) e004640
  • 13 Roskin J, Diviney J, Nanduri V. Presentation of childhood cancers to a paediatric shared care unit. Arch Dis Child 2015; 100 (12) 1131-1135
  • 14 Dang-Tan T, Trottier H, Mery LS. et al Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer 2008; 51 (04) 468-474
  • 15 Hansen RP, Olesen F, Sørensen HT, Sokolowski I, Søndergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res 2008; 8: 49
  • 16 Abdelmabood S, Kandil S, Megahed A, Fouda A. Delays in diagnosis and treatment among children with cancer: Egyptian perspective. East Mediterr Health J 2017; 23 (06) 422-429
  • 17 Abdelkhalek E, Sherief L, Kamal N, Soliman R. Factors associated with delayed cancer diagnosis in Egyptian children. Clin Med Insights Pediatr 2014; 8: 39-44
  • 18 Venkatasai JP, Srinivasamaharaj S, Sneha LM, Scott JX, Baby AK, Rajan M. Pediatric hematological malignancy: identification of issues involved in the road to diagnosis. South Asian J Cancer 2017; 6 (01) 28-30
  • 19 Begum M, Islam MJ, Akhtar MW, Karim S. Evaluation of delays in diagnosis and treatment of childhood malignancies in Bangladesh. South Asian J Cancer 2016; 5 (04) 192-193
  • 20 Sood N, Bendavid E, Mukherji A, Wagner Z, Nagpal S, Mullen P. Government health insurance for people below poverty line in India: quasi-experimental evaluation of insurance and health outcomes. BMJ 2014; 349: g5114
  • 21 Weller D, Vedsted P, Rubin G. et al The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012; 106 (07) 1262-1267
  • 22 Cecen E, Gunes D, Mutafoglu K, Sarialioglu F, Olgun N. The time to diagnosis in childhood lymphomas and other solid tumors. Pediatr Blood Cancer 2011; 57 (03) 392-397
  • 23 Lashkari HP, Faheem M, Sridevi Hanaganahalli B. et al Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome. Expert Rev Hematol 2020; 13 (10) 1143-1151
  • 24 Verma N, Bhattacharya S. Time to diagnosis and treatment of childhood cancer. Indian J Pediatr 2020; 87 (08) 641-643
  • 25 Brasme JF, Chalumeau M, Oberlin O, Valteau-Couanet D, Gaspar N. Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients. J Clin Oncol 2014; 32 (18) 1935-1940
  • 26 Saha V, Love S, Eden T, Micallef-Eynaud P, MacKinlay G. Determinants of symptom interval in childhood cancer. Arch Dis Child 1993; 68 (06) 771-774
  • 27 Mehta V, Chapman A, McNeely PD, Walling S, Howes WJ. Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study. Neurosurgery 2002; 51 (02) 365-372 discussion 372–373
  • 28 Shanmugavadivel D, Liu JF, Murphy L, Wilne S, Walker D. Accelerating diagnosis for childhood brain tumours: An analysis of the HeadSmart UK population data. Arch Dis Child 2020; doi: DOI: 10.1136/archdischild-2018-315962.
  • 29 Stefan DC, Siemonsma F. Delay and causes of delay in the diagnosis of childhood cancer in Africa. Pediatr Blood Cancer 2011; 56 (01) 80-85
  • 30 Araz NC, Guler E. Delays in diagnosis of childhood cancer in southeastern Turkey and the associated factors. Pediatr Hematol Oncol 2015; 32 (02) 153-163
  • 31 Haimi M, Peretz Nahum M, Ben Arush MW. Delay in diagnosis of children with cancer: a retrospective study of 315 children. Pediatr Hematol Oncol 2004; 21 (01) 37-48